What is left-ventricular end-diastolic area (LVEDA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is LVEDA?

LVEDA (Left Ventricular End-Diastolic Area) is the cross-sectional area of the left ventricle measured at end-diastole, typically obtained by echocardiography, and serves as a key parameter for assessing left ventricular size, preload, and function.

Definition and Measurement

LVEDA represents the maximum cross-sectional area of the left ventricular cavity at the end of diastolic filling, just before ventricular contraction begins. This measurement is obtained by tracing the endocardial border of the left ventricle in a short-axis or apical view during echocardiography 1.

The measurement is typically performed:

  • At the frame corresponding to the QRS complex on ECG
  • Just after mitral valve closure
  • When the left ventricular cavity is at its largest dimension 2

Clinical Applications

Assessment of Ventricular Preload and Volume Status

LVEDA serves as a volumetric estimate of left ventricular preload, which is more predictive of volume status than pressure-based measurements like central venous pressure or pulmonary capillary wedge pressure 3. Transoesophageal echocardiography is particularly useful for real-time assessment of LVEDA to guide volume management in critically ill patients 3.

Right Ventricular Function Assessment in ARDS

In patients with acute respiratory distress syndrome (ARDS), LVEDA is essential for calculating the RVEDA/LVEDA ratio, which identifies right ventricular dilatation and acute cor pulmonale 1. The interpretation is straightforward:

  • RVEDA/LVEDA ratio 0.6-1.0: Moderate RV dilatation
  • RVEDA/LVEDA ratio >1.0: Severe RV dilatation
  • RVEDA/LVEDA ratio >0.6 plus paradoxical septal motion: Diagnostic of acute cor pulmonale 1

This ratio assessment should be performed early in ARDS management to guide hemodynamic therapy and ventilator settings 1.

Calculation of Ejection Fraction

LVEDA can be used in conjunction with left ventricular end-systolic area (LVESA) to calculate fractional area change, which correlates with ejection fraction:

Fractional Area Change = (LVEDA - LVESA) / LVEDA × 100%

This provides a two-dimensional surrogate for volumetric ejection fraction assessment 2.

Technical Considerations

Imaging Modality

  • Transthoracic echocardiography (TTE): First-line, noninvasive approach for most patients
  • Transesophageal echocardiography (TEE): Superior when TTE windows are poor, particularly accurate for detecting acute cor pulmonale and measuring LVEDA in mechanically ventilated patients 1

Measurement Accuracy

LVEDA measurements correlate well with clinical volume status. In one study examining patients during cardiac surgery, LVEDA showed strong positive correlation (r = 0.81, p < 0.001) when measured before and after cardiopulmonary bypass at the same clinical volume marker 4.

Integration with Other Parameters

LVEDA should not be interpreted in isolation. The echocardiographic examination should include 1:

  • LV ejection fraction
  • Cardiac output
  • Markers of LV filling pressures
  • RV size and function
  • Assessment of valvular function

In critically ill patients, particularly those with ARDS or hemodynamic instability, LVEDA provides crucial information for distinguishing between hypovolemia, ventricular dysfunction, and vascular dysfunction, guiding targeted therapy with fluids, vasopressors, or adjustments to mechanical ventilation 1.

References

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
Can indapamide or amlodipine cause a right bundle branch block (RBBB)?
What is the importance of cross-matching blood before transfusion?
In a patient with suspected fat embolism syndrome and an elevated D-dimer, what is the appropriate management?
Can Voltaren (diclofenac) be given safely to a patient with β‑thalassemia major?
In a pregnant patient with systemic lupus erythematosus, what increase in proteinuria (or protein‑to‑creatinine ratio) or serum urea/creatinine defines active lupus nephritis?
Can carboplatin or gemcitabine cause cystitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.